The modern options of chronic hepatitis C antiviral therapy with daclatasvir: results of named patient program

The modern options of chronic hepatitis C antiviral therapy with daclatasvir: results of named patient program

Introduction. The options of antiviral therapy (AVT) in the stages of severe liver fibrosis and cirrhosis (LC) as well as in the patients with comorbidities for the long time were limited to the standard therapy by pegilated interferon (peg-IFN) in combination to ribavirin (RBV). Before official reg...

Full description

Saved in:
Bibliographic Details
Main Authors: V. T. Ivashkin, M. V. Mayevskaya, D. T. Abdurakhmanov, I. G. Bakulin, N. I. Geyvandova, M. L. Zubkin, S. N. Kizhlo, A. V. Kuznetsova, I. B. Latysheva, N. A. Mamonova, V. G. Morozov, O. I. Sagalova, Ye. V. Esaulenko, Ye. O. Lyusina
Format: Article
Language:Russian
Published: Gastro LLC 2018-08-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
hcv
хронический гепатит с
противовирусная терапия
даклатасвир
индивидуальный доступ
Online Access:https://www.gastro-j.ru/jour/article/view/192
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.gastro-j.ru/jour/article/view/192

Similar Items